Suppr超能文献

囊性前庭神经鞘瘤对放射外科治疗反应最佳。

Cystic Vestibular Schwannomas Respond Best to Radiosurgery.

作者信息

Bowden Greg, Cavaleri Jonathon, Monaco Edward, Niranjan Ajay, Flickinger John, Lunsford L Dade

机构信息

Department of Neurological Surgery, Pittsburgh, Pennsylvania.

Center for Image-Guided Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Penn-sylvania.

出版信息

Neurosurgery. 2017 Sep 1;81(3):490-497. doi: 10.1093/neuros/nyx027.

Abstract

BACKGROUND

Vestibular schwannomas (VS) have a well-documented response to Gamma Knife® (Elekta AB, Stockholm, Sweden) Stereotactic radiosurgery (SRS). However, there are limited data available regarding the volumetric response of cystic tumors.

OBJECTIVE

This report correlates the radiographic appearance of VS before radiosurgery with the delayed volumetric response.

METHODS

This study reviewed our SRS experience with 219 VS patients between 2003 and 2013. Patients were treatment naïve and had a significant extracanalicular tumor volume. Magnetic resonance imaging at the time of SRS identified 42 contrast-enhancing macrocystic tumors, 45 contrast-enhancing microcystic tumors, and 132 homogeneously enhancing tumors with no intratumoral cyst formation. The median follow-up was 49.1 months. The median tumor volume was 2.6 cm 3 (0.70-16.1 cm 3 ) and the median dose was 12.5 Gy (11-13 Gy).

RESULTS

The actuarial tumor control rate was 99.4% at 2 years and 96.4% at 5 years. A volumetric reduction of >20% occurred in 85.4% of macrocystic tumors, 76.1% of microcystic tumors, and 62.8% of homogeneously enhancing VS. The median volume decrease per year for macrocystic, microcystic, and homogenous tumors was 17.2%, 7.5%, and 7.9% per year respectively ( P < .001). A 2:1 blinded volumetric case match showed a significant size reduction in macrocystic tumors compared to noncystic tumors ( P = .007). Serviceable hearing was maintained in 61.5% of patients that had Gardner-Robertson grade I-II hearing before treatment. Surgical resection or repeat radiosurgery was performed in 8 patients (3.6%) who had sustained tumor progression.

CONCLUSION

SRS provided VS tumor control in >95% of patients, regardless of radiographic characteristics. Tumor volume regression was most evident in patients with cystic tumors.

摘要

背景

前庭神经鞘瘤(VS)对伽玛刀®(瑞典斯德哥尔摩的医科达公司)立体定向放射外科治疗(SRS)的反应已有充分记录。然而,关于囊性肿瘤体积反应的数据有限。

目的

本报告将放射外科治疗前VS的影像学表现与延迟体积反应相关联。

方法

本研究回顾了我们在2003年至2013年间对219例VS患者的SRS治疗经验。患者均为初治患者,且有显著的管外肿瘤体积。SRS时的磁共振成像识别出42例对比增强大囊性肿瘤、45例对比增强微囊性肿瘤和132例无瘤内囊肿形成的均匀强化肿瘤。中位随访时间为49.1个月。中位肿瘤体积为2.6 cm³(0.70 - 16.1 cm³),中位剂量为12.5 Gy(11 - 13 Gy)。

结果

2年时的精算肿瘤控制率为99.4%,5年时为96.4%。85.4%的大囊性肿瘤、76.1%的微囊性肿瘤和62.8%的均匀强化VS体积缩小>20%。大囊性、微囊性和均匀性肿瘤每年的中位体积减少分别为17.2%、7.5%和7.9%(P <.001)。一项2:1的双盲体积病例匹配显示,与非囊性肿瘤相比,大囊性肿瘤的大小有显著减小(P = 0.007)。治疗前Gardner-Robertson分级为I-II级听力水平的患者中,61.5%的患者听力得以保留。8例(3.6%)肿瘤持续进展的患者接受了手术切除或重复放射外科治疗。

结论

无论影像学特征如何,SRS在>95%的患者中实现了VS肿瘤控制。肿瘤体积退缩在囊性肿瘤患者中最为明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验